Blog

The clinical study is expected to conclude by next year, and if the findings demonstrate comparable effectiveness, the vaccine could be incorporated into the government’s nationwide vaccination programme after 2027. Reducing the schedule to a single dose would simplify vaccine delivery, improve compliance, and reduce costs for large-scale public health campaigns.